Salivary Gland Carcinoma — Trials

Salivary Gland Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

186 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 52
Recruiting: 25
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 22.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (21)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03291002	Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC	unknown	Phase 1	98	CureVacINDUSTRY	5	Nov 4, 2021	clinicaltrials
NCT01192087	Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy(ACCEPT)	unknown	Phase 1 / Phase 2	49	Heidelberg UniversityOTHER	1	Apr 24, 2013	clinicaltrials